未登录

C

Christina Jensen

University of Copenhagen

H指数:19

被引数:903

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Optimisation of a murine splenocyte mycobacterial growth inhibition assay using virulent Mycobacterium tuberculosis (vol 14, pg 7407, 2024)

SCIENTIFIC REPORTS

IF3.9

2024-03-280

OAAI

Non-invasive biomarkers of ECM turnover are prognostic for combinations of checkpoint inhibition immunotherapy in solid tumors

CANCER RESEARCH

IF16.6

2024-03-220

PRE

The association between fibrotic endotypes, determined by pre-treatment serum levels of collagen metabolites, and survival outcomes in patients with pancreatic cancer

ANNALS OF ONCOLOGY

IF65.4

2023-10-010

PRE

The collagen landscape in cancer: profiling collagens in tumors and in circulation reveals novel markers of cancer-associated fibroblast subtypes

JOURNAL OF PATHOLOGY

IF5.2

2023-09-2016

OAAI

Regulation of tumor immunity and immunotherapy by the tumor collagen extracellular matrix

FRONTIERS IN IMMUNOLOGY

IF5.9

2023-08-1726

OAAI

Importance of fibrillar collagen quality, not quantity, for patients with solid tumors

CANCER RESEARCH

IF16.6

2023-04-040

PRE

Non-invasive biomarkers quantifying collagens essential for embryogenesis are elevated in the circulation of solid tumor patients and may guide drug development

CANCER RESEARCH

IF16.6

2023-04-040

PRE

High serum levels of the C-propetide of type V collagen (PRO-C5) are prognostic for short overall survival in patients with pancreatic ductal adenocarcinoma

FRONTIERS IN MOLECULAR BIOSCIENCES

IF4

2023-03-106

OAAI

Blood-based tumor fibrosis markers as diagnostic and prognostic biomarkers in patients with biliary tract cancer

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2022-12-018

PRE

Type XXII Collagen Complements Fibrillar Collagens in the Serological Assessment of Tumor Fibrosis and the Outcome in Pancreatic Cancer

IF5.2

2022-11-2414

OAAI

BLOOD-BASED EXTRACELLULAR MATRIX BIOMARKERS ARE CORRELATED WITH PROGNOSTIC AND FIBROTIC-RELATED CLINICAL CHARACTERISTICS AND LIVER FUNCTION MARKERS IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2022-11-070

OA

KNOCKOUT OF COLLAGEN TYPE I IMPEDES TUMOR GROWTH AND SUPPORTS IMMUNE CELL INFILTRATION IN A MURINE MODEL OF PANCREATIC CANCER

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2022-11-070

OA

Biomarker potential of collagens linked to fibroblast subtypes in pancreatic ductal adenocarcinoma (PDAC)

ANNALS OF ONCOLOGY

IF65.4

2022-09-010

OA

Fibrotic activity quantified in serum by measurements of type III collagen pro-peptides can be used for prognosis across different solid tumor types

CELLULAR AND MOLECULAR LIFE SCIENCES

IF6.2

2022-03-2518

OAAI

THE POTENTIAL OF SERUM AUTOANTIBODIES AGAINST TYPE III COLLAGEN IN CANCER

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2021-11-100

OA

NEUTROPHIL EXTRACELLULAR TRAPS (NETS) CAN BE MEASURED NON-INVASIVELY WITH CPA9-HNE BIOMARKER POTENTIAL ACROSS DIFFERENT SOLID TUMOR TYPES IN THE IMMUNO-ONCOLOGY SETTING

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2021-11-100

OA

Serological assessment of collagen fragments and tumor fibrosis may guide immune checkpoint inhibitor therapy

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

IF12.8

2021-10-1622

OAAI

Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR-collagen interaction

IF0

2021-06-1453

OA

Prognostic value of blood-based fibrosis biomarkers in patients with metastatic colorectal cancer receiving chemotherapy and bevacizumab

SCIENTIFIC REPORTS

IF3.9

2021-01-1321

OAAI

Cross-Linked Multimeric Pro-Peptides of Type III Collagen (PC3X) in Hepatocellular Carcinoma - A Biomarker That Provides Additional Prognostic Value in AFP Positive Patients

JOURNAL OF HEPATOCELLULAR CARCINOMA

IF3.4

2020-11-0121

OAAI